Dr. Juan G Ramirez Malave , MD
General Practice • Bayamon, PR
Bayamon Medical Mall Ofc, Suite 307
Bayamon, PR 009597200
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Juan Ramirez Malave is listed in NPPES under General Practice.
-
NPI assigned on July 19, 2016; this date does not establish years in practice.
-
Published CMS data list 441 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Descovy (Emtricitabine/Tenofov Alafenam) — 88 prescription fills, including refills.
- Dovato (Dolutegravir Sodium/Lamivudine) — 85 prescription fills, including refills.
- Rosuvastatin Calcium — 59 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 17 records in the table · Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Part D prescriptions among clinicians listed under General Practice in Bayamon, PR (2024, 149 clinicians with data). Median for this group: 602. Middle half: 146 to 2,942.
Fewer Part D prescriptions than 65% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: 1,253. Middle half: 239 to 5,097.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 675 in 2020 to 441 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
Bayamon Medical Mall Ofc
Suite 307
Bayamon, PR 009597200
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
General Practice: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
612 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$619,410 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $554.75 across 21 records.
By nature of payment
- Food and Beverage: $554.75 across 21 records.
Reporting-company totals (3 largest of 5)
- ViiV Healthcare Company: $205.53 across 9 records.
- Janssen Pharmaceuticals, Inc: $148.83 across 5 records.
- Gilead Sciences, Inc.: $124.84 across 4 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Bayamon and Puerto Rico
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Close to the middle for clinicians listed under General Practice in Bayamon, PR (2024, 149 clinicians with data). Median for this group: 602. Middle half: 146 to 2,942.
Fewer Part D prescriptions than 65% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: 1,253. Middle half: 239 to 5,097.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under General Practice in Bayamon, PR (2024, 149 clinicians with data). Median for this group: $10,805. Middle half: $2,337 to $164,977.
A higher Part D drug cost than 90% of clinicians listed under General Practice in Puerto Rico (2024, 2,628 clinicians with data). Median for this group: $34,007. Middle half: $2,958 to $213,188.
275 active clinicians are listed under General Practice with a practice address in Bayamon, PR (4,196 in Puerto Rico).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bayamon
0.4% of these 275 clinicians have the CMS telehealth indicator.
25.5% of these 275 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 35% from 675 in 2020 to 441 in 2024.
- 2020: 675
- 2021: 723
- 2022: 796
- 2023: 425
- 2024: 441
-
30-day fills
30-day fills decreased 23% from 797 in 2020 to 612 in 2024.
- 2020: 797
- 2021: 797
- 2022: 974
- 2023: 545
- 2024: 612
-
Part D drug cost
Part D drug cost increased 15% from $540,080 in 2020 to $619,410 in 2024.
- 2020: $540,080
- 2021: $550,704
- 2022: $684,256
- 2023: $544,666
- 2024: $619,410
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $207.00 in 2021 to $554.75 in 2025.
- 2021: $207.00
- 2022: $612.77
- 2023: $479.77
- 2024: $761.55
- 2025: $554.75
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 21 records totaling $554.75.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $34.77 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $34.77 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SYMTUZA | General | $34.50 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SYMTUZA | General | $33.00 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SYMTUZA | General | $32.50 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $31.10 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $30.30 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
DOVATO | General | $30.00 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $27.08 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SYMTUZA | General | $26.88 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
CABENUVA | General | $26.04 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
DELSTRIGO | General | $25.00 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
APRETUDE | General | $25.00 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $25.00 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
DOVATO | General | $25.00 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
DOVATO | General | $25.00 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
GARDASIL 9 | General | $23.47 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
SYMTUZA | General | $21.95 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
DOVATO | General | $20.46 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
APRETUDE | General | $17.78 |
| ViiV Healthcare Company |
Food and Beverage
In-kind items and services
|
APRETUDE | General | $5.15 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Descovy | Emtricitabine/Tenofov Alafenam | 88 | 2,910 | $215,408.70 | 15 |
| Dovato | Dolutegravir Sodium/Lamivudine | 85 | 2,970 | $294,576.23 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 59 | 2,850 | $478.11 | 14 |
| Amlodipine Besylate | Amlodipine Besylate | 23 | 870 | $93.32 | — |
| Synthroid | Levothyroxine Sodium | 20 | 1,620 | $2,744.21 | — |
| Metoprolol Succinate | Metoprolol Succinate | 19 | 1,170 | $480.53 | — |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | 1,470 | $2,240.64 | — |
| Gabapentin | Gabapentin | 15 | 750 | $80.40 | — |
| Levothyroxine Sodium | Levothyroxine Sodium | 15 | 750 | $148.12 | — |
| Pentoxifylline | Pentoxifylline | 15 | 450 | $385.53 | — |
| Triumeq | Abacavir/Dolutegravir/Lamivudi | 15 | 450 | $55,879.50 | — |
| Terazosin Hcl | Terazosin Hcl | 12 | 360 | $161.64 | — |
| Valacyclovir | Valacyclovir Hcl | 12 | 360 | $333.46 | — |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | 390 | $100.35 | — |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 11 | 330 | $221.96 | — |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 11 | 330 | $43,735.01 | — |
| Tadalafil | Tadalafil | 11 | 330 | $2,342.23 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-10-02NUCC Taxonomy Code: 208D00000X
A physician who specializes in the general practice of diagnosing, treating, and managing patients with a variety of illnesses and conditions.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Surgery
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Record officially reactivated for active practice on October 02, 2020
Registered at BAYAMON MEDICAL MALL OFC, SUITE 307, BAYAMON, PR 009597200 (Tel: 7877873535)
Registered at BAYAMON MEDICAL MALL, SUITE 307, BAYAMON, PR 009597200 (Tel: 7877873535)
Recorded as JUAN RAMIREZ MALAVE, MD
General Practice (license number reported to NPPES: PR 19434)
NPPES lists this NPI as deactivated as of September 08, 2020; the reason is not published.
NPI status registered as active in NPPES database
Registered at BAYAMON MEDICAL MALL OFC, SUITE 307, BAYAMON, PR 009597200 (Tel: 7877873535)
Registered at BAYAMON MEDICAL MALL, SUITE 307, BAYAMON, PR 009597200 (Tel: 7877873535)
Recorded as JUAN RAMIREZ MALAVE, MD
General Practice (license number reported to NPPES: PR 19434)
NPI status registered as active in NPPES database
Registered at BAYAMON MEDICAL MALL, SUITE 305, BAYAMON, PR 009597200 (Tel: 7877873535)
Registered at BAYAMON MEDICAL MALL, SUITE 305, BAYAMON, PR 009597200 (Tel: 7877873535)
Recorded as JUAN RAMIREZMALAVE, MD
General Practice (license number reported to NPPES: PR 19434)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other General Practices in Bayamon
- Dr. Jesus Sierra Diaz, MD
- Dr. Brenda Jimenez Rivera, MD
- Alex Concepcion Ruiz
- Dr. Omar Berrios Torres, MD
- Dr. Evelyn Cintron Pagan, MD
- Dr. Francisco Menendez Diaz, MD
More public profiles in Puerto Rico
Directory navigation, in NPI number order.
- Joaquin Davila-Quinones, MD Internal Medicine · Patillas
- Lisannette Ramirez, MD Internal Medicine · San Juan
- Mariela Romero-Diaz, MD Emergency Medicine · Humacao
- Edgardo Colon-Zavala, MD Psychiatry & Neurology - Neurology · San Juan
- Raphael Colon-Hernandez, MD Emergency Medicine · San Juan
- Yadira Santiago Nieves, MD Psychiatry & Neurology - Psychiatry · Hatillo
- Jose Colon-Grau, MD Emergency Medicine - Hospice and Palliative Medicine · Bayamon
- Marysol Castritius, DMD Dentist · Camuy
- Alex Nieves, MD General Practice · Salinas
- Hector Rivera, MSW Social Worker - Clinical · Coamo
- Juan Hernandez, MD General Practice · Aguadilla
- Joel Cordero, RPH Pharmacist · San Juan
Mailing Address
Bayamon Medical Mall, Suite 307
Bayamon, PR 009597200
Phone: 7877873535